Literature DB >> 11376903

Patterns of retinal ganglion cell survival after brain-derived neurotrophic factor administration in hypertensive eyes of rats.

M L Ko1, D N Hu, R Ritch, S C Sharma, C F Chen.   

Abstract

We investigated the effect of brain-derived neurotrophic factor (BDNF) on retinal ganglion cell (RGC) survival after intraocular pressure (IOP) elevation at various time intervals. In adult Wistar rats, RGCs were labeled with 5% Fluorogold. Animals with 1.8-2.5-fold increase in IOP after cauterization of three episcleral vessels, were divided into three BDNF groups and three vehicle control groups, each receiving one, two or three injections. The RGC survival percentage on RGCs of the first, second and third injections were 93.9% (n = 7), 91.3% (n = 7), 82.7% (n = 5), respectively in BDNF groups; 91.6% (n = 6), 84.1% (n = 6) and 73.5% (n = 5), respectively in vehicle controls. The second and third injections of BDNF showed statistically significant survival effects. These findings demonstrated that BDNF has partial neuroprotection on RGCs in whole retina and enhances RGC survival in moderately chronic hypertensive eyes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11376903     DOI: 10.1016/s0304-3940(01)01830-4

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  47 in total

1.  Transplantation of BDNF-secreting mesenchymal stem cells provides neuroprotection in chronically hypertensive rat eyes.

Authors:  Matthew M Harper; Sinisa D Grozdanic; Bas Blits; Markus H Kuehn; Daniel Zamzow; Janice E Buss; Randy H Kardon; Donald S Sakaguchi
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-23       Impact factor: 4.799

Review 2.  Potential neuroprotective biomolecules in ophthalmology.

Authors:  Mehrdad Afarid; Fatemeh Sanie-Jahromi
Journal:  Int Ophthalmol       Date:  2020-11-12       Impact factor: 2.031

3.  Relationship between Sigma-1 receptor and BDNF in the visual system.

Authors:  Barbara A Mysona; Jing Zhao; Sylvia Smith; Kathryn E Bollinger
Journal:  Exp Eye Res       Date:  2017-10-12       Impact factor: 3.467

Review 4.  Mechanisms of retinal ganglion cell injury and defense in glaucoma.

Authors:  Juan Qu; Danyi Wang; Cynthia L Grosskreutz
Journal:  Exp Eye Res       Date:  2010-04-13       Impact factor: 3.467

Review 5.  Progress of mesenchymal stem cell therapy for neural and retinal diseases.

Authors:  Tsz Kin Ng; Veronica R Fortino; Daniel Pelaez; Herman S Cheung
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

6.  Characterization of retinal damage in the episcleral vein cauterization rat glaucoma model.

Authors:  John Danias; Fran Shen; Manolis Kavalarakis; Bin Chen; David Goldblum; Kevin Lee; Maria-Florencia Zamora; YanLing Su; Scott E Brodie; Steven M Podos; Thom Mittag
Journal:  Exp Eye Res       Date:  2005-08-16       Impact factor: 3.467

Review 7.  Neurotrophin roles in retinal ganglion cell survival: lessons from rat glaucoma models.

Authors:  Elaine C Johnson; Ying Guo; William O Cepurna; John C Morrison
Journal:  Exp Eye Res       Date:  2009-02-14       Impact factor: 3.467

8.  Neuroprotective effects of intravitreal mesenchymal stem cell transplantation in experimental glaucoma.

Authors:  Thomas V Johnson; Natalie D Bull; David P Hunt; Nephtali Marina; Stanislav I Tomarev; Keith R Martin
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-11-20       Impact factor: 4.799

9.  Failure of axonal transport induces a spatially coincident increase in astrocyte BDNF prior to synapse loss in a central target.

Authors:  S D Crish; J D Dapper; S E MacNamee; P Balaram; T N Sidorova; W S Lambert; D J Calkins
Journal:  Neuroscience       Date:  2012-11-14       Impact factor: 3.590

Review 10.  What can we learn about stroke from retinal ischemia models?

Authors:  Philippe M D'Onofrio; Paulo D Koeberle
Journal:  Acta Pharmacol Sin       Date:  2012-12-03       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.